Literature DB >> 8908814

Interleukin 2 and its receptors: recent advances and new immunological functions.

J Thèze1, P M Alzari, J Bertoglio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8908814     DOI： 10.1016/0167-5699(96)10057-c

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  28 in total

Review 1.  Cell receptors and cell signalling.

Authors:  I J Uings; S N Farrow
Journal:  Mol Pathol       Date:  2000-12

2.  Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis.

Authors:  Andras Komocsi; Peter Lamprecht; Elena Csernok; Antje Mueller; Konstanze Holl-Ulrich; Ulrike Seitzer; Frank Moosig; Armin Schnabel; Wolfgang Ludwig Gross
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

3.  Ameliorative action of Vernonia cinerea L. on cyclophosphamide-induced immunosuppression and oxidative stress in mice.

Authors:  P Pratheeshkumar; Girija Kuttan
Journal:  Inflammopharmacology       Date:  2010-05-15       Impact factor: 4.473

Review 4.  Advances in immunosuppression for renal transplantation.

Authors:  Antoine Durrbach; Helene Francois; Severine Beaudreuil; Antoine Jacquet; Bernard Charpentier
Journal:  Nat Rev Nephrol       Date:  2010-02-02       Impact factor: 28.314

Review 5.  Polyunsaturated fatty acids and T-cell function: implications for the neonate.

Authors:  C J Field; M T Clandinin; J E Van Aerde
Journal:  Lipids       Date:  2001-09       Impact factor: 1.880

6.  Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients.

Authors:  H J Ankersmit; B Moser; A Zuckermann; G Roth; S Taghavi; M Brunner; E Wolner; G Boltz-Nitulescu
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

7.  Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus.

Authors:  S A Litherland; X T Xie; A D Hutson; C Wasserfall; D S Whittaker; J X She; A Hofig; M A Dennis; K Fuller; R Cook; D Schatz; L L Moldawer; M J Clare-Salzler
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

8.  Reduced susceptibility to dextran sulphate sodium-induced colitis in the interleukin-2 heterozygous (IL-2) mouse.

Authors:  Malin Sund; Li Li Xu; Arman Rahman; Bi-Feng Qian; Marie-Louise Hammarström; Ake Danielsson
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

Review 9.  Immunological weapons against acute myeloid leukaemia.

Authors:  Joanna Galea-Lauri
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

10.  Discordant effects of interleukin-2 on viral and immune parameters in human immunodeficiency virus-1-infected monocyte-derived mature dendritic cells.

Authors:  G M Bahr; E C A Darcissac; Y Mouton
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.